Search results
Author(s):
Barry Hennigan
,
Keith Robertson
,
Colin Berry
,
et al
Added:
3 years ago
The original studies of coronary balloon angioplasty performed by Andreas Gruentzig attempted to employ physiological guidance by measuring trans-stenotic gradients with over-the-wire angioplasty catheters.1 However, these catheters were of such large calibre that they contributed to the stenosis being assessed and in addition, measurements were made at rest as the importance of assessing…
View more
Author(s):
Clemens von Birgelen
Added:
5 years ago
Prof Clemens von Birgelen (University of Twente, Overijssel, Twente, NL) discusses 3-years BIO-RESORT - results of the 3-arm randomised study in all-comers, treated with contemporary biodegradable or durable polymer-coated drug-eluting stents.
Filmed on site at CRT 2019 by Radcliffe Cardiology.
Questions:
1. What is BIO-RESORT and why was it conducted?
2. Could you summarise the study design…
View more
Author(s):
Justin E Davies
Start date:
Oct 13, 2014
On-Demand Video:
Clinical Utilisation of Fractional Flow Reserve in Multi-Vessel Disease
Monday 13th October 2014 (14:30-15:30 BST)
View more
Author(s):
Binita Shah
Added:
4 years ago
Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI).
Questions:
1.What is colchicine and why study it in PCI?
2.What was the study design, patient population and primary and secondary outcomes?
3.What were your outcomes?
4.How do these compare to those in the COLCOT study?
5.How should your study be interpreted in clinical…
View more
CRT 2019: SAVAL Trial
Author(s):
Jihad Mustapha
Added:
5 years ago
Video
Author(s):
Joanna J Wykrzykowska
Added:
4 years ago
Dr Joanna J Wykrzykowska (Academic Medical Center, Amsterdam, NL) discusses Updates from the AIDA trial - Comparison of ABSORB BRS with Xience everolimus-eluting metallic stent in routine PCI.
Questions:
1. Can you remind us of the story of the AIDA clinical study programme to date?
2. How should we interpret the new three-year follow-up data and have we learned anything new?
3. As a result…
View more
Author(s):
Nick West
Added:
4 years ago
Dr Nick West (Royal Papworth Hospital, Cambridge, UK) discusses The ABSORB UK registry - Final three-year outcomes of patients receiving everolimus-eluting BRS in real-world practice.
Questions:
1. What is the ABSORB UK registry and what data are you presenting at EuroPCR 2019?
2. What were the major findings from ABSORB UK and does the three-year data tell us anything different?
3. As a…
View more
EuroPCR 2023: Late-Breaking Science Video Collection
Author(s):
D Scott Lim
,
Sandeep Arunothayaraj
,
Paul Sorajja
Added:
11 months ago
Video Series
Jeffrey W Moses
Research Area(s) / Expertise:
Job title: Director of Interventional Cardiovascular Therapeutics
Author
Author(s):
Petr Tousek
Added:
4 years ago
Assoc. ProfPetr Toušek (University Hospital Královské Vinohrady, Prague, CZ) discusses PRAGUE-19 study - BRS implantation in STEMI patients: five-year follow-up of PRAGUE-19 study.
Questions:
1. What is the PRAGUE-19 study and why was it conducted?
2. Could you describe the design and associated endpoints?
3. How should we interpret the new five-year follow-up data tell us and have we learned…
View more